↑ parent activity group ·
research dossier →

NCPDP FOUNDATION

SCOTTSDALE, AZ · EIN 462161880 · Form 990 · FY2022 · NTEE B82 · Education · Small ($100K-$1M) · www.ncpdpfoundation.org
revenue
$441K
expenses
$498K
net assets
$6.8M
employees
0
program ratio
62%
mission · from form 990

SUPPORT PROGRAMS, PROJECTS AND PEOPLE THAT DRIVE QUALITY HEALTHCARE THROUGH THE USE OF STANDARDS-BASED HIT TO IMPROVE OUTCOMES.

profile · synthesized from sources

The NCPDP Foundation is a grantmaking organization that funds research projects and white papers focused on healthcare interoperability and pharmacy standards. It aims to improve patient safety, expand the role of pharmacists, increase patient access to care, and empower care coordination through the use of health information technology. The Foundation primarily supports research conducted by other organizations.

named programs · 4 · from sources

what they call their work

Empower Coordination of Care & Innovation
Supports data standardization and interoperability to connect providers and ensure better continuity of care.
Enhance Patient Safety
Funds research to reduce medication errors through better standards, technologies, and evidence-based best practices.
Expand the Role & Value of the Pharmacist
Prioritizes funding grants researching the benefits of pharmacists operating at the top of their license.
Increase Patient Access to Care
Funds research that improves medication affordability and pharmacy access to eliminate barriers to care.
activities · 7 groups

what they do

  • Pharmacist Reimbursement & RTPB Research 18 activities
    • Funding Research on Patient Access to Prescription Information via Mobile Apps
      Funds research, including an $83,025 grant, analyzing patient access to real-time prescription benefit information via mobile applications.
    • Funding Research on Pharmacist Clinical Care and Collaboration
      Funds research on reimbursement for pharmacists providing clinical care services and projects demonstrating the value of physician/pharmacist collaboration using pharmacist eCare plans, with grants up to $99,302.
    • Funding Research on Pharmacist Clinical Care and Collaboration
      Funds research on reimbursement for pharmacists providing clinical care services and demonstrating the value of physician/pharmacist collaboration using pharmacist eCare plans, with grants up to $99,302.
    • Funding Research on Pharmacist Reimbursement and Clinical Care
      Funds research, including a $98,000 grant, on reimbursement for pharmacists providing clinical care services and demonstrating the value of physician/pharmacist collaboration using pharmacist eCare plans.
    • Funding Research on Pharmacist Reimbursement and Collaboration
      Funds research on reimbursement for pharmacists providing clinical care services and demonstrating the value of physician/pharmacist collaboration using pharmacist eCare plans, with grants up to $99,302.
    • Funding Research on Pharmacist Reimbursement and Collaboration
      Funds research on reimbursement for pharmacists providing clinical care services and projects demonstrating the value of physician/pharmacist collaboration using pharmacist eCare plans, with grants up to $99,302.
    • Funding Research on Real-Time Prescription Benefit (RTPB) Tools
      Funds research projects, including grants of $149,123 and $200,000, to study the benefits of patient use of RTPB tools and to align consumer-facing RTPB tools with NCPDP Prescriber RTPB standards.
    • Funding Research on Real-Time Prescription Benefit (RTPB) Tools
      Funds research projects focused on the benefits of patient use of real-time prescription benefit (RTPB) tools, aligning consumer-facing RTPB tools with NCPDP Prescriber RTPB standards, and analyzing patient access to RTPB information via mobile apps, with grants up to $200,000.
    • Funding Research on Real-Time Prescription Benefit (RTPB) Tools
      Funds research projects focused on the benefits of patient use of real-time prescription benefit (RTPB) tools, aligning consumer-facing RTPB tools with NCPDP Prescriber RTPB standards, and analyzing patient access to RTPB information via mobile apps, with grants up to $200,000.
    • Funding research on patient access to RTPB via mobile apps
      Funds research analyzing how patients access real-time prescription benefit information through mobile applications, supported by an $83,025 grant with results published in July 2025.
    • Funding research on pharmacist reimbursement and clinical care
      Funds research on reimbursement models for pharmacists providing clinical care services, including a $98,000 grant with results published in March 2026.
    • Funding research on physician/pharmacist collaboration via eCare Plans
      Funds research demonstrating the value of physician/pharmacist collaboration using Pharmacist eCare Plans, supported by a $99,302 grant with results published in August 2025.
    • Funding research on real-time prescription benefit (RTPB) tools
      Funds research to evaluate the benefits of patient and consumer-facing use of real-time prescription benefit (RTPB) tools, including alignment with NCPDP Prescriber RTPB standards. Supported by grants totaling $149,123 and $200,000.
    • General Research Funding
      Provides over $2.4 million in funding to grantees for research in areas including empowering coordination of care and innovation, enhancing patient safety, expanding the role and value of pharmacists, and increasing patient access to care, managing 4 ongoing projects and producing over 20 published results.
    • General Research Funding
      Provides over $2.4 million in funding to grantees for research in areas including empowering coordination of care and innovation, enhancing patient safety, expanding the role and value of pharmacists, and increasing patient access to care, managing 4 ongoing projects and producing over 20 published results.
    • General Research Funding and Management
      Provides over $2.4 million in funding to grantees for research in areas such as empowering coordination of care, enhancing patient safety, expanding the role of pharmacists, and increasing patient access to care, managing 4 ongoing projects and producing over 20 published research results.
    • Managing Research Projects
      Manages 4 ongoing research projects and has provided over $2.4 million in funding to grantees, resulting in over 20 published research results, focusing on areas like care coordination, patient safety, and expanding the role of pharmacists.
    • Managing research grants and producing published results
      Has provided over $2.4 million in funding to grantees, produced over 20 published research results, and currently manages 4 ongoing research projects.
  • Pharmacist Workflow Integration Research 12 activities
    • Funding Research on Digital Therapeutics (DTx) and RxFill
      Funds research on Digital Therapeutics (DTx) integration and workflow, and on RxFill as an innovative approach to support medication adherence.
    • Funding Research on Digital Therapeutics (DTx) and RxFill
      Funds research on Digital Therapeutics (DTx) integration and workflow, and on RxFill as an innovative approach to support medication adherence.
    • Funding Research on Digital Therapeutics (DTx) and RxFill
      Funds research on Digital Therapeutics (DTx) integration and workflow, and on RxFill as an innovative approach to support medication adherence.
    • Funding Research on Pharmacist Clinical Recommendations and NLP
      Funds research on tracking the adoption of pharmacists’ clinical recommendations and utilizing Natural Language Processing (NLP) to standardize medication directions and automate acceptance of pharmacist recommendations.
    • Funding Research on Pharmacist Clinical Recommendations and NLP
      Funds research on tracking the adoption of pharmacists’ clinical recommendations and utilizing Natural Language Processing (NLP) to standardize medication directions and automate acceptance of pharmacist recommendations.
    • Funding Research on Pharmacist Clinical Recommendations and NLP
      Funds research on tracking the adoption of pharmacists’ clinical recommendations and utilizing Natural Language Processing (NLP) to standardize medication directions and automate acceptance of pharmacist recommendations.
    • Funding Research on Pharmacogenomics (PGx) Data Integration
      Funds research on integrating pharmacogenomics (PGx) data into pharmacist workflows.
    • Funding Research on Pharmacogenomics (PGx) and Pharmacist Workflows
      Funds research focused on integrating pharmacogenomics (PGx) data into pharmacist workflows.
    • Funding Research on Pharmacogenomics (PGx) and Pharmacist Workflows
      Funds research on integrating pharmacogenomics (PGx) data into pharmacist workflows.
    • Funding Research on Pharmacogenomics (PGx) and Pharmacist Workflows
      Funds research focused on integrating pharmacogenomics (PGx) data into pharmacist workflows.
    • Funding research on NLP for pharmacist clinical recommendations
      Funds research on tracking pharmacist clinical recommendations and using Natural Language Processing (NLP) to standardize medication directions and automate acceptance of recommendations.
    • Funding research on pharmacogenomics (PGx) integration into pharmacy workflows
      Funds research on integrating pharmacogenomics (PGx) data into pharmacist workflows to support clinical decision-making.
  • Pharmacy Interoperability & Data Standards Research 9 activities
    • Funding Phase 2 of the National Facilitator Model research
      Funds Phase 2 of the National Facilitator Model research initiative to advance pharmacy practice and care coordination.
    • Funding Research on Pharmacy Interoperability
      Funds research providing a comprehensive assessment of the current landscape of pharmacy interoperability.
    • Funding Research on Pharmacy Interoperability
      Funds research providing a comprehensive assessment of the current landscape of pharmacy interoperability.
    • Funding Research on Pharmacy Interoperability and Data Quality
      Funds research providing a comprehensive assessment of the current landscape of pharmacy interoperability and evaluating the NCPDP/HL7® FHIR® Specialty Medication Enrollment Implementation Guidance for data quality and usefulness.
    • Funding Research on Pharmacy Interoperability and Data Quality
      Funds research providing a comprehensive assessment of the current landscape of pharmacy interoperability and evaluating the NCPDP/HL7® FHIR® Specialty Medication Enrollment Implementation Guidance for data quality and usefulness.
    • Funding Research on Specialty Medication Enrollment Implementation Guidance
      Funds research evaluating the NCPDP/HL7® FHIR® Specialty Medication Enrollment Implementation Guidance for data quality and usefulness.
    • Funding Research on Specialty Medication Enrollment Implementation Guidance
      Funds research evaluating the NCPDP/HL7® FHIR® Specialty Medication Enrollment Implementation Guidance for data quality and usefulness.
    • Funding research on pharmacy interoperability landscape
      Funds comprehensive research assessing the current state of pharmacy interoperability to identify gaps and opportunities for improvement.
    • Funding research on specialty medication enrollment data quality
      Funds research evaluating the NCPDP/HL7® FHIR® Specialty Medication Enrollment Implementation Guidance for data quality and practical usefulness.
  • Behavioral Health Counselor Certification 5 activities
    • Funding Research on RxChange Messages
      Funds research on the utilization patterns of RxChange messages for pharmacist and prescriber communications regarding ePrescriptions, and to enhance patient safety and expand the role of pharmacists.
    • Funding Research on RxChange Messages
      Funds research on the utilization patterns of RxChange messages for pharmacist and prescriber communications regarding ePrescriptions to enhance patient safety and expand the role of pharmacists.
    • Funding Research on RxChange Messages
      Funds research on the utilization patterns of RxChange messages for pharmacist and prescriber communications regarding ePrescriptions, and to enhance patient safety and expand the role and value of the pharmacist.
    • Funding Research on RxChange Messages
      Funds research on the utilization patterns of RxChange messages for pharmacist and prescriber communications regarding ePrescriptions, and to enhance patient safety and expand the role of pharmacists.
    • Funding research on RxChange message utilization
      Funds research on the use of RxChange messages for pharmacist and prescriber communication regarding ePrescriptions, with additional focus on enhancing patient safety and expanding pharmacist roles.
  • Wild Horse Emergency Feeding & Water Provision 4 activities
    • Funding Research on Risk Evaluation and Mitigation Strategies (REMS)
      Funds research, including a $190,000 grant, to streamline data exchange for Risk Evaluation and Mitigation Strategies (REMS).
    • Funding Research on Risk Evaluation and Mitigation Strategies (REMS)
      Funds research to streamline data exchange for Risk Evaluation and Mitigation Strategies (REMS), providing grants up to $190,000.
    • Funding Research on Risk Evaluation and Mitigation Strategies (REMS)
      Funds research to streamline data exchange for Risk Evaluation and Mitigation Strategies (REMS), providing grants up to $190,000.
    • Funding research on REMS data exchange
      Funds research to streamline data exchange for Risk Evaluation and Mitigation Strategies (REMS), with grants totaling $190,000.
  • Charity Galas and Auctions 1 activity
    • Organizing fundraising and awareness events
      Organizes and staffs fundraising and awareness events such as Denim & Diamonds and the 5K Run.Walk.Roll to support foundation initiatives.
  • Uncategorized 4 activities
    • Funding National Facilitator Model Research
      Funds both Phase 1 and Phase 2 of the National Facilitator Model research.
    • Funding National Facilitator Model Research
      Funds both Phase 1 and Phase 2 of the National Facilitator Model research.
    • Funding Research on the National Facilitator Model
      Funds both Phase 1 and Phase 2 of the National Facilitator Model research.
    • Funding Research on the National Facilitator Model
      Funds Phase 1 and Phase 2 of the National Facilitator Model research.
financials · form 990 · fy2022
revenue
Total revenue$441K
Contributions & grants$455K103%
Program service revenue$-14K-3%
Investment income$00%
Other revenue$0
expenses
Total expenses$498K
Program expenses62%
Admin / overhead38%
Fundraising0%
Salaries & benefits$0
Grants paid out$307K
Largest expense lineProfessional Fees
balance sheet
Total assets$6.81M
Cash$1.94M
Investments$0
Liabilities$24K
Net assets$6.78M
Liquid reserves46.7 mo
3 years on record · 2020–2022 · YoY revenue -80.1%
leadership · form 990 part vii · fy2022

who runs it

board members · 14
  • BRIAN CORREIA — DIRECTOR
  • GREG PULIDO — DIRECTOR
  • JOHN HILL — EXECUTIVE DI
  • LEE ANN STEMBER — DIRECTOR
  • MARA MITCHEL — DIRECTOR
  • MICHAEL BASSOFF — DIRECTOR
  • MICHAEL BUKACH — CHAIR
  • MICHAEL MCBRIDE — DIRECTOR
  • MICHAEL SATTERFIELD — DIRECTOR
  • MICHELE DAVIDSON — DIRECTOR
  • MICHELLE VANCURA — VICE CHAIR
  • MINDY SMITH — DIRECTOR
  • PAMELA SCHWITZER — DIRECTOR
  • RICHARD BROOK — SECRETARY/TR
relationships · 34

who they work with

  • 5K Run.Walk.Roll Partner — Community event organized and staffed by the organization
  • Denim & Diamonds Partner — Fundraising and awareness event supported by the organization
  • Digital Therapeutic Alliance Partner — Grantee for research on Digital Therapeutics (DTx) integration and workflow.
  • InfoWerks Partner — Grantee for research on streamlining data exchange for REMS.
  • InfoWerks Partner — Grantee researching streamlined data exchange for Risk Evaluation and Mitigation Strategies (REMS).
  • Leavitt Partners Partner — Grantee for research on synchronizing consumer-facing RTPB implementations with NCPDP Prescriber RTPB standards.
  • Leavitt Partners Partner — Grantee for research on synchronizing consumer-facing RTPB implementations.
  • Leavitt Partners Partner — Grantee working to synchronize consumer-facing RTPB implementations with NCPDP Prescriber RTPB standards.
  • MedStar Health Partner — Grantee for research on RxChange Messages.
  • MedStar Health Partner — Grantee, along with Quandary peak, for research on RxChange Messages.
  • NCPDP Partner — Focuses on how NCPDP standards can be implemented to improve in-workflow processes and enhance interoperability.
  • NYU Grossman School of Medicine Partner — Grantee conducting research on patient use of real-time prescription benefit tools.
  • NYU Grossman School of Medicine Partner — Grantee for research on benefits of patients using RTPB.
  • NYU Grossman School of Medicine Partner — Grantee for research on the benefits of patients using Real-Time Prescription Benefit (RTPB).
  • Point-of-Care Partners Partner — Grantee for research on pharmacy interoperability.
  • Quandary peak Partner — Grantee for research on RxChange Messages.
  • Quandary peak Partner — Grantee, along with MedStar Health, for research on RxChange Messages.
  • RxEOB.com, LLC Partner — Grantee for research on patient access to real-time prescription benefit information via mobile app.
  • RxEOB.com, LLC Partner — Grantee for research on patient access via mobile app to real-time prescription benefit information.
  • RxLive Partner — Grantee for research on tracking adoption of pharmacists’ clinical recommendations and utilizing NLP.
  • STChealth Partner — Grantee for Phase 1 and Phase 2 of the National Facilitator Model research.
  • STChealth Partner — Grantee for Phase 2 of the National Facilitator Model research.
  • Summit Health Partner — Grantee for research on reimbursement for pharmacists providing clinical care services.
  • Surescipts Partner — Grantee for research evaluating NCPDP/HL7® FHIR® Specialty Medication Enrollment Implementation Guidance.
  • Surescipts Partner — Grantee, along with University of Minnesota College of Pharmacy, for research evaluating NCPDP/HL7® FHIR® Specialty Medication Enrollment Implementation Guidance.
  • University of Michigan Partner — Grantee for research on utilization patterns of RxChange messages for pharmacist & prescriber communications regarding ePrescriptions.
  • University of Michigan Partner — Grantee for research on utilization patterns of RxChange messages for pharmacist and prescriber communications regarding ePrescriptions.
  • University of Minnesota College of Pharmacy Partner — Grantee for research evaluating NCPDP/HL7® FHIR® Specialty Medication Enrollment Implementation Guidance.
  • University of Minnesota College of Pharmacy Partner — Grantee, along with Surescripts, for research evaluating NCPDP/HL7® FHIR® Specialty Medication Enrollment Implementation Guidance.
  • University of Tennessee Health Science Center College of Pharmacy Partner — Grantee for research demonstrating the value of physician/pharmacist collaboration using pharmacist eCare plans.
+ 4 more